Impact of Conversational Approaches in Pediatric Social Robot-Mediated Interventions
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-9
SponsorSamsung Medical Center
About this trial
This study examines how different robot dialogue systems (rule-based vs. large language model-based) and content types (emotional support vs. safety education) affect pediatric patients' responses during hospital-based robot-mediated interventions.
Approximately 60 pediatric patients aged 2-9 years will be randomly assigned to interact with a social robot (LIKU) using either rule-based or LLM-based dialogue. Each child will participate in two activity sessions (emotional content and safety content) in randomized order.
Primary outcomes include child engagement, emotional responses, robot perception, and activity preferences, assessed through standardized questionnaires (UEQ, Godspeed), child interviews, and behavioral observations. Additionally, 5 experts will evaluate content appropriateness and safety.
This pilot study aims to provide foundational data for developing personalized pediatric robot programs in hospital settings, optimizing both dialogue approaches and content design based on individual child characteristics.
Eligibility criteria
Qualifiers
Pediatric patients aged 2-9 years
Currently admitted to or visiting Samsung Medical Center pediatric ward or outpatient clinic
Capable of cognitive communication as determined by experienced medical staff
Written informed consent from parent/legal guardian obtained
Disqualifiers
Diagnosis of moderate to severe developmental delay (language or cognitive) documented in medical records
Currently in isolation treatment (e.g., due to infectious disease)
Experiencing acute pain, fever, or medical procedures that make study participation difficult
Parent/guardian or child declined participation or withdrew consent
Trial design
Treatments tested in this trial
- Robot-Mediated Emotional Support Activity
- Robot-Mediated Safety Education Activity
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov